Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Spectranetics Cp T (SPNC)

Spectranetics Cp T (SPNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spectranetics Cp T 9965 FEDERAL DRIVE COLORADO SPRINGS CO 80921 USA

www.spectranetics.com P: 719-633-8333

Description:

Spectranetics Corp. is a medical device company engaged in the development, manufacturing, marketing and distribution of its technology for interventional cardiovascular therapy. The Company's CVX-300 excimer laser system is the only excimer laser system approved by the FDA for multiple cardiovascular procedures. The technology has been designed for use in multiple cardiovascular applications, including coronary angioplasty and the removal of pacemaker and ICD leads. (press release)

Key Statistics

Overview:

Market Capitalization, $K 1,686,033
Shares Outstanding, K 43,850
Annual Sales, $ 270,820 K
Annual Net Income, $ -58,120 K
Last Quarter Sales, $ 74,710 K
Last Quarter Net Income, $ -24,600 K
60-Month Beta 1.55
% of Insider Shareholders 3.70%
% of Institutional Shareholders 91.95%

Growth:

1-Year Return 60.01%
3-Year Return 40.17%
5-Year Return 208.09%
5-Year Revenue Growth 112.76%
5-Year Earnings Growth -1,387.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.56 on 08/03/17
Next Earnings Date N/A
Earnings Per Share ttm -1.42
EPS Growth vs. Prev Qtr -30.23%
EPS Growth vs. Prev Year -115.38%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SPNC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -85.52%
Return-on-Assets % -14.57%
Profit Margin % -21.46%
Debt/Equity 3.83
Price/Sales 6.23
Price/Cash Flow N/A
Price/Book 40.93
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar